Semin Liver Dis 2013; 33(03): 213-225
DOI: 10.1055/s-0033-1351778
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interventional Radiology in the Multidisciplinary Management of Liver Lesions: Pre- and Postoperative Roles

Thomas J. Ward
1   Department of Radiology, Mount Sinai Medical Center, New York
,
David C. Madoff
2   Department of Radiology, Weill Cornell Medical College, New York
,
Joshua L. Weintraub
3   Department of Radiology, Columbia University Medical Center, New York
› Author Affiliations
Further Information

Publication History

Publication Date:
13 August 2013 (online)

Abstract

The management algorithm for patents with liver lesions, most often hepatocellular carcinoma (HCC) or colorectal cancer metastasis, are complex, ever-changing, and involve multiple treatment modalities including chemotherapy, external-beam radiation, surgery, and locoregional therapies (LRTs). This complexity necessitates a multidisciplinary approach including hepatologists, oncologists, hepatobiliary surgeons, radiation oncologists, and interventional radiologists to coordinate and deliver the complex care that these patients need in a timely manner. The interventional radiologist and hepatobiliary surgeon work closely together in both the pre- and postoperative setting. Preoperative roles include delivering LRTs to patients with HCC and interventions aimed at hepatic optimization prior to resection or transplantation. LRT in this setting is performed either to bridge the patient to transplant or to downstage the initially nontransplant candidate so appropriate transplant criteria are met. Postoperative roles include the management of biliary and vascular complications that may occur after resection or transplantation.

 
  • References

  • 1 Mazzaferro V, Regalia E, Doci R , et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334 (11) 693-699
  • 2 Freeman RB, Edwards EB, Harper AM. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006; 6 (6) 1416-1421
  • 3 Livraghi T, Meloni F, Di Stasi M , et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?. Hepatology 2008; 47 (1) 82-89
  • 4 Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology 2007; 72 (Suppl. 01) 124-131
  • 5 Seifert JK, Morris DL. World survey on the complications of hepatic and prostate cryotherapy. World J Surg 1999; 23 (2) 109-113 , discussion 113–114
  • 6 Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 2011; 104 (1) 22-28
  • 7 Cannon R, Ellis S, Hayes D, Narayanan G, Martin II RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 2013; 107 (5) 544-549
  • 8 Marelli L, Stigliano R, Triantos C , et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007; 30 (1) 6-25
  • 9 Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37 (2) 429-442
  • 10 Lammer J, Malagari K, Vogl T , et al; PRECISION V Investigators. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 2010; 33 (1) 41-52
  • 11 Kulik LM, Atassi B, van Holsbeeck L , et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 2006; 94 (7) 572-586
  • 12 Hilgard P, Hamami M, Fouly AE , et al. Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 2010; 52 (5) 1741-1749
  • 13 Carr BI. Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl 2004; 10 (2) (Suppl. 01) S107-S110
  • 14 Yao FY, Bass NM, Nikolai B , et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy. Liver Transpl 2003; 9 (7) 684-692
  • 15 Pomfret EA, Washburn K, Wald C , et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010; 16 (3) 262-278
  • 16 Mazzaferro V, Battiston C, Perrone S , et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004; 240 (5) 900-909
  • 17 Maddala YK, Stadheim L, Andrews JC , et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10 (3) 449-455
  • 18 Freeman Jr RB, Steffick DE, Guidinger MK, Farmer DG, Berg CL, Merion RM. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008; 8 (4 Pt 2) 958-976
  • 19 Chapman WC, Majella Doyle MB, Stuart JE , et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008; 248 (4) 617-625
  • 20 Yao FY, Kerlan Jr RK, Hirose R , et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48 (3) 819-827
  • 21 Lewandowski RJ, Kulik LM, Riaz A , et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 2009; 9 (8) 1920-1928
  • 22 Jarnagin WR, Gonen M, Fong Y , et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236 (4) 397-406 , discussion 406–407
  • 23 Shirabe K, Shimada M, Gion T , et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999; 188 (3) 304-309
  • 24 Mullen JT, Ribero D, Reddy SK , et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204 (5) 854-862 , discussion 862–864
  • 25 Truty MJ, Vauthey JN. Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol 2010; 37 (2) 102-109
  • 26 Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 2003; 227 (1) 251-260
  • 27 Kishi Y, Abdalla EK, Chun YS , et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009; 250 (4) 540-548
  • 28 Siriwardana RC, Lo CM, Chan SC, Fan ST. Role of portal vein embolization in hepatocellular carcinoma management and its effect on recurrence: a case-control study. World J Surg 2012; 36 (7) 1640-1646
  • 29 Kubota K, Makuuchi M, Kusaka K , et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26 (5) 1176-1181
  • 30 Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 2006; 13 (10) 1271-1280
  • 31 Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005; 16 (6) 779-790
  • 32 Avritscher R, de Baere T, Murthy R, Deschamps F, Madoff DC. Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes. Semin Intervent Radiol 2008; 25 (2) 132-145
  • 33 Yoo H, Kim JH, Ko GY , et al. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma. Ann Surg Oncol 2011; 18 (5) 1251-1257
  • 34 Ogata S, Belghiti J, Farges O, Varma D, Sibert A, Vilgrain V. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 2006; 93 (9) 1091-1098
  • 35 Hirai I, Kimura W, Fuse A, Suto K, Urayama M. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003; 133 (5) 495-506
  • 36 Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996; 223 (1) 77-83
  • 37 Abulkhir A, Limongelli P, Healey AJ , et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008; 247 (1) 49-57
  • 38 Farges O, Belghiti J, Kianmanesh R , et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003; 237 (2) 208-217
  • 39 Okabe H, Beppu T, Ishiko T , et al. Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival. J Surg Oncol 2011; 104 (6) 641-646
  • 40 Azoulay D, Castaing D, Smail A , et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231 (4) 480-486
  • 41 Popescu I, Alexandrescu ST. Surgical options for initially unresectable colorectal liver metastases. HPB Surg 2012; 2012: 454026 10.1155/2012/454026
  • 42 Wicherts DA, de Haas RJ, Andreani P , et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases. Br J Surg 2010; 97 (2) 240-250
  • 43 Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88 (2) 165-175
  • 44 Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007; 94 (11) 1386-1394
  • 45 Shindoh J, Truty MJ, Aloia TA , et al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 2013; 216 (2) 201-209
  • 46 Kennedy TJ, Yopp A, Qin Y , et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 2009; 11 (5) 445-451
  • 47 Nuzzo G, Giuliante F, Ardito F , et al; Italian Chapter of the International Hepato-Pancreato-Biliary Association. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 2012; 147 (1) 26-34
  • 48 Giuliante F, Ardito F, Vellone M, Nuzzo G. Liver resections for hilar cholangiocarcinoma. Eur Rev Med Pharmacol Sci 2010; 14 (4) 368-370
  • 49 Rocha FG, Matsuo K, Blumgart LH, Jarnagin WR. Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience. J Hepatobiliary Pancreat Sci 2010; 17 (4) 490-496
  • 50 Li SQ, Liang LJ, Peng BG, Lu MD, Lai JM, Li DM. Bile leakage after hepatectomy for hepatolithiasis: risk factors and management. Surgery 2007; 141 (3) 340-345
  • 51 Marsh RdeW, Alonzo M, Bajaj S , et al. Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management. J Surg Oncol 2012; 106 (3) 339-345
  • 52 Kanai M, Nimura Y, Kamiya J , et al. Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery 1996; 119 (5) 498-504
  • 53 Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 2002; 236 (1) 17-27
  • 54 Wang Q, Gurusamy KS, Lin H, Xie X, Wang C. Preoperative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev 2008; (3) CD005444
  • 55 Fang Y, Gurusamy KS, Wang Q , et al. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev 2012; 9: CD005444
  • 56 Ferrero A, Lo Tesoriere R, Viganò L, Caggiano L, Sgotto E, Capussotti L. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg 2009; 33 (2) 318-325
  • 57 Gouma DJ. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma (Br J Surg 2013; 100: 274-283). Br J Surg 2013; 100 (2) 283-284
  • 58 Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg 2013; 257 (2) 191-204
  • 59 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey WD ; Practice Guidelines Committee of American Association for Study of Liver Diseases; Practice Parameters Committee of American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007; 46 (3) 922-938
  • 60 García-Pagán JC, Caca K, Bureau C , et al; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362 (25) 2370-2379
  • 61 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43 (1) 167-176
  • 62 Narahara Y, Kanazawa H, Fukuda T , et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 2011; 46 (1) 78-85
  • 63 Salerno F, Merli M, Riggio O , et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 2004; 40 (3) 629-635
  • 64 Goldberg MS, Weppler D, Khan FA , et al. Does transjugular intrahepatic portosystemic shunting facilitate or complicate liver transplantation?. Transplant Proc 1997; 29 (1-2) 557-559
  • 65 Guerrini GP, Pleguezuelo M, Maimone S , et al. Impact of tips preliver transplantation for the outcome posttransplantation. Am J Transplant 2009; 9 (1) 192-200
  • 66 Bauer J, Johnson S, Durham J , et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 2006; 12 (10) 1544-1551
  • 67 D'Avola D, Bilbao JI, Zozaya G , et al. Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation. Transplant Proc 2012; 44 (9) 2603-2605
  • 68 Luca A, Miraglia R, Caruso S , et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 60 (6) 846-852
  • 69 Francoz C, Valla D, Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012; 57 (1) 203-212
  • 70 Lendoire J, Raffin G, Cejas N , et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007; 9 (5) 352-356
  • 71 Pereira AA, Bhattacharya R, Carithers R, Reyes J, Perkins J. Clinical factors predicting readmission after orthotopic liver transplantation. Liver Transpl 2012; 18 (9) 1037-1045
  • 72 Robles R, Fernandez JA, Hernández Q , et al. Eversion thromboendovenectomy in organized portal vein thrombosis during liver transplantation. Clin Transplant 2004; 18 (1) 79-84
  • 73 Francoz C, Belghiti J, Vilgrain V , et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54 (5) 691-697
  • 74 Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010; 16 (8) 999-1005
  • 75 Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000; 32 (3) 466-470
  • 76 Sheen CL, Lamparelli H, Milne A, Green I, Ramage JK. Clinical features, diagnosis and outcome of acute portal vein thrombosis. QJM 2000; 93 (8) 531-534
  • 77 Zocco MA, Di Stasio E, De Cristofaro R , et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51 (4) 682-689
  • 78 Shah V. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. J Clin Gastroenterol 2007; 41 (Suppl. 03) S259-S261
  • 79 Radosevich PM, Ring EJ, LaBerge JM , et al. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology 1993; 186 (2) 523-527
  • 80 Han G, Qi X, He C , et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011; 54 (1) 78-88
  • 81 Bilbao JI, Elorz M, Vivas I, Martínez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 2004; 27 (5) 474-480
  • 82 Saxon RS, Ross PL, Mendel-Hartvig J , et al. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology 1998; 207 (3) 683-693
  • 83 Nazarian GK, Ferral H, Castañeda-Zúñiga WR , et al. Development of stenoses in transjugular intrahepatic portosystemic shunts. Radiology 1994; 192 (1) 231-234
  • 84 Vignali C, Bargellini I, Grosso M , et al. TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study. AJR Am J Roentgenol 2005; 185 (2) 472-480
  • 85 Bureau C, Garcia-Pagan JC, Otal P , et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004; 126 (2) 469-475
  • 86 Rossi P, Salvatori FM, Fanelli F , et al. Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience. Radiology 2004; 231 (3) 820-830
  • 87 Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212 (2) 411-421
  • 88 Tripathi D, Therapondos G, Redhead DN, Madhavan KK, Hayes PC. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol 2002; 14 (8) 827-832
  • 89 Selvaggi G, Weppler D, Nishida S , et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant 2007; 7 (2) 454-460
  • 90 Petersen B, Uchida BT, Timmermans H, Keller FS, Rosch J. Intravascular US-guided direct intrahepatic portacaval shunt with a PTFE-covered stent-graft: feasibility study in swine and initial clinical results. J Vasc Interv Radiol 2001; 12 (4) 475-486
  • 91 Petersen BD, Clark TW. Direct intrahepatic portocaval shunt. Tech Vasc Interv Radiol 2008; 11 (4) 230-234
  • 92 Hoppe H, Wang SL, Petersen BD. Intravascular US-guided direct intrahepatic portocaval shunt with an expanded polytetrafluoroethylene-covered stent-graft. Radiology 2008; 246 (1) 306-314
  • 93 Boyer TD, Haskal ZJ ; American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology 2010; 51 (1) 306
  • 94 Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997; 46 (1) 8-14
  • 95 Patel A, Fischman AM, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices. AJR Am J Roentgenol 2012; 199 (4) 721-729
  • 96 Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol 1984; 143 (3) 627-628
  • 97 Tripathi D, Therapondos G, Jackson E, Redhead DN, Hayes PC. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51 (2) 270-274
  • 98 Kitamoto M, Imamura M, Kamada K , et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol 2002; 178 (5) 1167-1174
  • 99 Saad WE, Nicholson D, Koizumi J. Inventory used for balloon-occluded retrograde (BRTO) and antegrade (BATO) transvenous obliteration: sclerosants and balloon occlusion devices. Tech Vasc Interv Radiol 2012; 15 (3) 226-240
  • 100 Thuluvath PJ, Atassi T, Lee J. An endoscopic approach to biliary complications following orthotopic liver transplantation. Liver Int 2003; 23 (3) 156-162
  • 101 Greif F, Bronsther OL, Van Thiel DH , et al. The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg 1994; 219 (1) 40-45
  • 102 García-Pajares F, Sánchez-Antolín G, Pelayo SL , et al. Covered metal stents for the treatment of biliary complications after orthotopic liver transplantation. Transplant Proc 2010; 42 (8) 2966-2969
  • 103 Zoepf T, Maldonado-Lopez EJ, Hilgard P , et al. Balloon dilatation vs. balloon dilatation plus bile duct endoprostheses for treatment of anastomotic biliary strictures after liver transplantation. Liver Transpl 2006; 12 (1) 88-94
  • 104 Atar E, Bachar GN, Bartal G , et al. Use of peripheral cutting balloon in the management of resistant benign ureteral and biliary strictures. J Vasc Interv Radiol 2005; 16 (2 Pt 1) 241-245
  • 105 Gwon DI, Shim HJ, Kwak BK. Retrievable biliary stent-graft in the treatment of benign biliary strictures. J Vasc Interv Radiol 2008; 19 (9) 1328-1335
  • 106 Ko GY, Sung KB, Yoon HK, Kim KR, Gwon DI, Lee SG. Percutaneous transhepatic treatment of hepaticojejunal anastomotic biliary strictures after living donor liver transplantation. Liver Transpl 2008; 14 (9) 1323-1332
  • 107 Kim ES, Lee BJ, Won JY, Choi JY, Lee DK. Percutaneous transhepatic biliary drainage may serve as a successful rescue procedure in failed cases of endoscopic therapy for a post-living donor liver transplantation biliary stricture. Gastrointest Endosc 2009; 69 (1) 38-46
  • 108 Mueller PR, vanSonnenberg E, Ferrucci Jr JT , et al. Biliary stricture dilatation: multicenter review of clinical management in 73 patients. Radiology 1986; 160 (1) 17-22
  • 109 Born P, Rösch T, Brühl K , et al. Long-term results of endoscopic and percutaneous transhepatic treatment of benign biliary strictures. Endoscopy 1999; 31 (9) 725-731
  • 110 Kim JH, Gwon DI, Ko GY , et al. Temporary placement of retrievable fully covered metallic stents versus percutaneous balloon dilation in the treatment of benign biliary strictures. J Vasc Interv Radiol 2011; 22 (6) 893-899
  • 111 Hoekstra LT, van Gulik TM, Gouma DJ, Busch OR. Posthepatectomy bile leakage: how to manage. Dig Surg 2012; 29 (1) 48-53
  • 112 Ishii H, Ochiai T, Murayama Y , et al. Risk factors and management of postoperative bile leakage after hepatectomy without bilioenteric anastomosis. Dig Surg 2011; 28 (3) 198-204
  • 113 Weber A, Gaa J, Rosca B , et al. Complications of percutaneous transhepatic biliary drainage in patients with dilated and nondilated intrahepatic bile ducts. Eur J Radiol 2009; 72 (3) 412-417
  • 114 Kühn JP, Busemann A, Lerch MM, Heidecke CD, Hosten N, Puls R. Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts compared with patients with dilated intrahepatic bile ducts. AJR Am J Roentgenol 2010; 195 (4) 851-857
  • 115 Gwon DI, Ko GY, Sung KB, Kim JH, Yoon HK. Percutaneous transhepatic treatment of postoperative bile leaks: prospective evaluation of retrievable covered stent. J Vasc Interv Radiol 2011; 22 (1) 75-83
  • 116 Fiocca F, Salvatori FM, Fanelli F , et al. Complete transection of the main bile duct: minimally invasive treatment with an endoscopic-radiologic rendezvous. Gastrointest Endosc 2011; 74 (6) 1393-1398
  • 117 Cozzi G, Severini A, Civelli E , et al. Percutaneous transhepatic biliary drainage in the management of postsurgical biliary leaks in patients with nondilated intrahepatic bile ducts. Cardiovasc Intervent Radiol 2006; 29 (3) 380-388
  • 118 Funaki B, Zaleski GX, Straus CA , et al. Percutaneous biliary drainage in patients with nondilated intrahepatic bile ducts. AJR Am J Roentgenol 1999; 173 (6) 1541-1544
  • 119 Ernst O, Sergent G, Mizrahi D, Delemazure O, L'Herminé C. Biliary leaks: treatment by means of percutaneous transhepatic biliary drainage. Radiology 1999; 211 (2) 345-348
  • 120 Righi D, Franchello A, Ricchiuti A , et al. Safety and efficacy of the percutaneous treatment of bile leaks in hepaticojejunostomy or split-liver transplantation without dilatation of the biliary tree. Liver Transpl 2008; 14 (5) 611-615
  • 121 da Silva RF, Raphe R, Felício HC , et al. Prevalence, treatment, and outcomes of the hepatic artery stenosis after liver transplantation. Transplant Proc 2008; 40 (3) 805-807
  • 122 Saad WE. Management of hepatic artery steno-occlusive complications after liver transplantation. Tech Vasc Interv Radiol 2007; 10 (3) 207-220
  • 123 Rostambeigi N, Hunter D, Duval S, Chinnakotla S, Golzarian J. Stent placement versus angioplasty for hepatic artery stenosis after liver transplant: a meta-analysis of case series. Eur Radiol 2013; 23 (5) 1323-1334
  • 124 Saad WE, Davies MG, Saad NE , et al. Catheter thrombolysis of thrombosed hepatic arteries in liver transplant recipients: predictors of success and role of thrombolysis. Vasc Endovascular Surg 2007; 41 (1) 19-26
  • 125 Singhal A, Stokes K, Sebastian A, Wright HI, Kohli V. Endovascular treatment of hepatic artery thrombosis following liver transplantation. Transpl Int 2010; 23 (3) 245-256
  • 126 Lerut J, Tzakis AG, Bron K , et al. Complications of venous reconstruction in human orthotopic liver transplantation. Ann Surg 1987; 205 (4) 404-414
  • 127 Brouwers MA, de Jong KP, Peeters PM, Bijleveld CM, Klompmaker IJ, Slooff MJ. Inferior vena cava obstruction after orthotopic liver transplantation. Clin Transplant 1994; 8 (1) 19-22
  • 128 Darcy MD. Management of venous outflow complications after liver transplantation. Tech Vasc Interv Radiol 2007; 10 (3) 240-245
  • 129 Zajko AB, Sheng R, Bron K, Reyes J, Nour B, Tzakis A. Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol 1994; 5 (1) 121-126
  • 130 Kubo T, Shibata T, Itoh K , et al. Outcome of percutaneous transhepatic venoplasty for hepatic venous outflow obstruction after living donor liver transplantation. Radiology 2006; 239 (1) 285-290
  • 131 Ko GY, Sung KB, Yoon HK, Lee S. Early posttransplantation portal vein stenosis following living donor liver transplantation: percutaneous transhepatic primary stent placement. Liver Transpl 2007; 13 (4) 530-536
  • 132 Funaki B, Rosenblum JD, Leef JA , et al. Percutaneous treatment of portal venous stenosis in children and adolescents with segmental hepatic transplants: long-term results. Radiology 2000; 215 (1) 147-151